370 related articles for article (PubMed ID: 9487348)
21. Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa.
Herrmann G; Yang L; Wu H; Song Z; Wang H; Høiby N; Ulrich M; Molin S; Riethmüller J; Döring G
J Infect Dis; 2010 Nov; 202(10):1585-92. PubMed ID: 20942647
[TBL] [Abstract][Full Text] [Related]
22. Toxicity of colistin in cystic fibrosis patients.
Bosso JA; Liptak CA; Seilheimer DK; Harrison GM
DICP; 1991 Nov; 25(11):1168-70. PubMed ID: 1763528
[TBL] [Abstract][Full Text] [Related]
23. [Nebulized colistin versus tobramycin in the treatment of chronic Pseudomonas colonization in cystic fibrosis patients].
Quintana-Gallego E; Lopez-Campos JL; Calero C; Dapena FJ
Med Clin (Barc); 2014 Jan; 142(2):59-63. PubMed ID: 23369499
[TBL] [Abstract][Full Text] [Related]
24. [Usefulness of parenteral colistin in treating of lower respiratory infection due to multidrug-resistant Pseudomonas aeruginosa].
Endo R; Ishiguro N; Kikuta H
Kansenshogaku Zasshi; 2005 Dec; 79(12):945-50. PubMed ID: 16444976
[TBL] [Abstract][Full Text] [Related]
25. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.
Waters V; Ratjen F
Cochrane Database Syst Rev; 2008 Jul; (3):CD006961. PubMed ID: 18646176
[TBL] [Abstract][Full Text] [Related]
26. Oral Azithromycin Use and the Recovery of Lung Function from Pulmonary Exacerbations Treated with Intravenous Tobramycin or Colistimethate in Adults with Cystic Fibrosis.
Somayaji R; Russell R; Cogen JD; Goss CH; Nick SE; Saavedra MT; Taylor-Cousar JL; Nick JA; Nichols DP
Ann Am Thorac Soc; 2019 Jul; 16(7):853-860. PubMed ID: 30840835
[No Abstract] [Full Text] [Related]
27. Home versus hospital intravenous antibiotic therapy in the treatment of young adults with cystic fibrosis.
Pond MN; Newport M; Joanes D; Conway SP
Eur Respir J; 1994 Sep; 7(9):1640-4. PubMed ID: 7995394
[TBL] [Abstract][Full Text] [Related]
28. Nebulized tobramycin in the treatment of adult CF pulmonary exacerbations.
Al-Aloul M; Nazareth D; Walshaw M
J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):299-305. PubMed ID: 24219814
[TBL] [Abstract][Full Text] [Related]
29. Intravenous antibiotics reduce the presence of Aspergillus in adult cystic fibrosis sputum.
Baxter CG; Rautemaa R; Jones AM; Webb AK; Bull M; Mahenthiralingam E; Denning DW
Thorax; 2013 Jul; 68(7):652-7. PubMed ID: 23513028
[TBL] [Abstract][Full Text] [Related]
30. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
Banerjee D; Stableforth D
Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
[TBL] [Abstract][Full Text] [Related]
31. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis.
Frederiksen B; Koch C; Høiby N
Pediatr Pulmonol; 1997 May; 23(5):330-5. PubMed ID: 9168506
[TBL] [Abstract][Full Text] [Related]
32. [Inhaled colistin in cystic fibrosis].
Tamm M; Eich C; Frei R; Gilgen S; Breitenbücher A; Mordasini C
Schweiz Med Wochenschr; 2000 Sep; 130(39):1366-72. PubMed ID: 11059027
[TBL] [Abstract][Full Text] [Related]
33. [Experience with nebulised colistin in patients with non-cystic fibrosis bronchiectasis colonised with Pseudomonas aeruginosa].
López-Gil Otero MM; Romero-Ventosa EY; Feijoo-Meléndez D; Casanova-Martínez C; Otero-Millán L; Piñeiro-Corrales G
Rev Esp Quimioter; 2019 Jun; 32(3):217-223. PubMed ID: 30924621
[TBL] [Abstract][Full Text] [Related]
34. Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics.
Etherington C; Bosomworth M; Clifton I; Peckham DG; Conway SP
J Cyst Fibros; 2007 Jan; 6(1):67-73. PubMed ID: 16844430
[TBL] [Abstract][Full Text] [Related]
35. Sequential Inhalational Tobramycin-Colistin-Combination in CF-Patients with Chronic P. Aeruginosa Colonization - an Observational Study.
Riethmüller J; Herrmann G; Graepler-Mainka U; Hellwig D; Heuer HE; Heyder S; Köster H; Kinder B; Kröger K; Paul K; Poplawska K; Melichar VO; Smaczny C; Mellies U
Cell Physiol Biochem; 2016; 39(3):1141-51. PubMed ID: 27576543
[TBL] [Abstract][Full Text] [Related]
36. Efficacy, safety, and local pharmacokinetics of highly concentrated nebulized tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa.
Lenoir G; Antypkin YG; Miano A; Moretti P; Zanda M; Varoli G; Monici Preti PA; Aryayev NL
Paediatr Drugs; 2007; 9 Suppl 1():11-20. PubMed ID: 17536871
[TBL] [Abstract][Full Text] [Related]
37. [The revival of colistin: an old antibiotic for the 21st century].
Nasnas R; Saliba G; Hallak P
Pathol Biol (Paris); 2009 May; 57(3):229-35. PubMed ID: 18178335
[TBL] [Abstract][Full Text] [Related]
38. Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis.
Cheer SM; Waugh J; Noble S
Drugs; 2003; 63(22):2501-20. PubMed ID: 14609360
[TBL] [Abstract][Full Text] [Related]
39. Nebulized Colistin And Continuous Cyclic Azithromycin In Severe COPD Patients With Chronic Bronchial Infection Due To
Montón C; Prina E; Pomares X; Cugat JR; Casabella A; Oliva JC; Gallego M; Monsó E
Int J Chron Obstruct Pulmon Dis; 2019; 14():2365-2373. PubMed ID: 31802860
[TBL] [Abstract][Full Text] [Related]
40. Elective versus symptomatic antibiotic treatment in cystic fibrosis patients with chronic Pseudomonas infection of the lungs.
Elborn JS; Prescott RJ; Stack BH; Goodchild MC; Bates J; Pantin C; Ali N; Shale DJ; Crane M
Thorax; 2000 May; 55(5):355-8. PubMed ID: 10770814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
